Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimaging probes, known as CPNs™, are set […]

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimaging probes, known as CPNs™, are set […]

BALTIMORE — PathSensors and Ensensor Japan have entered into a partnership to bring novel pathogen detection devices to markets in Japan. Ensensor is a bio-detection company created in joint venture with S.T. Japan, a well-known organization that specializes in selling products such as spectra databases, microscopy accessories, and analytical instruments. The company has become a distributor of PathSensors’ CANARY […]

ST. LOUIS – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc., (LSBio). The Company is a founder-led developer and distributor of antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform. Terms of the […]

Chromatographers now have another tool for analyzing intact mAb’s via reversed-phase: YMC-Triart Bio C4 YMC-Triart Bio C4 was developed specifically for HPLC and UHPLC separations of intact antibodies and other large proteins. This hybrid-silica based butyl phase is especially effective when used for intact antibody analysis at high temperatures and is ideal for high-sensitivity analysis […]

Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market LEXINGTON, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field. The termination of the license […]

Proteins are the building blocks of life. They form the structure of cells, regulate cellular activity and carry out the biochemical processes that underpin function in every living organism. To understand proteins and their function, we must understand the way they fold, aggregate and interact. Fluidic Analytics Ltd, Cambridge UK, has announced the global launch […]

BURLINGAME, Calif. – Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow. VECTASHIELD Vibrance produces increased brightness over the entire visible spectrum, including far-red fluorophores, compared to existing mounting-media offerings. VECTASHIELD Vibrance produces […]

Visiopharm Phenomap software presented at the Fluidigm Imaging Mass Cytometry User Group Meeting, expanding the suite of Hyperion Imaging System data analysis tools for translational and clinical research  SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) and Visiopharm A/S today announced a co-marketing relationship to automate image analysis for Imaging Mass Cytometry™ (IMC™). Under the terms of this […]

Former Chief Operations Officer and Delta™ System developer Ariel Notcovich promoted to drive industry adoption of the company’s core biomolecule characterization platform SOUTH SAN FRANCISCO, Calif. – Biodesy, Inc., a next-generation biomolecule characterization company, today announced the promotion of Ariel G. Notcovich to Chief Executive Officer, and the completion of a $20 million Series C financing. […]